SAB Biotherapeutics, Inc. earnings per share and revenue

SABS earnings per share for the last quarter are -1.19 USD whereas the estimation was -1.16 USD which accounts for -1.80% surprise. Company revenue for the same period amounts to 50.00 k USD despite the estimated figure of 120.00 k USD. Estimated earnings per share for the next quarter are -1.01 USD, and revenue is expected to reach 250.00 k USD. Also watch annual changes over time to get a bigger picture of SABS earnings per share and revenue dynamics.